These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34929561)

  • 1. Galectin-3 is linked to peripheral artery disease severity, and urinary excretion is associated with long-term mortality.
    Ursli M; Zierfuss B; Grigassy T; Pesau G; Koppensteiner R; Schernthaner GH; Höbaus C
    Atherosclerosis; 2022 Jan; 341():7-12. PubMed ID: 34929561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YKL-40 levels increase with declining ankle-brachial index and are associated with long-term cardiovascular mortality in peripheral arterial disease patients.
    Höbaus C; Tscharre M; Herz CT; Pesau G; Wrba T; Koppensteiner R; Schernthaner GH
    Atherosclerosis; 2018 Jul; 274():152-156. PubMed ID: 29783062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrosis and Inflammatory Markers and Long-Term Risk of Peripheral Artery Disease: The ARIC Study.
    Ding N; Yang C; Ballew SH; Kalbaugh CA; McEvoy JW; Salameh M; Aguilar D; Hoogeveen RC; Nambi V; Selvin E; Folsom AR; Heiss G; Coresh J; Ballantyne CM; Matsushita K
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2322-2331. PubMed ID: 32698688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Trefoil Factor-3 Predicts Survival in Peripheral Artery Disease.
    Pesau G; Zierfuss B; Hoebaus C; Koppensteiner R; Schernthaner GH
    Angiology; 2024 Feb; ():33197241230973. PubMed ID: 38312093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary vanin-1 as a novel biomarker for survival in peripheral artery disease.
    Zierfuss B; Karlinger A; Bojic M; Koppensteiner R; Schernthaner GH; Höbaus C
    Vasc Med; 2024 Apr; ():1358863X241240428. PubMed ID: 38607943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
    Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
    Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble urokinase-type plasminogen activator receptor predicts peripheral artery disease severity and outcomes.
    Höbaus C; Ursli M; Yussef SM; Wrba T; Koppensteiner R; Schernthaner GH
    Vasc Med; 2021 Feb; 26(1):11-17. PubMed ID: 33448911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic value of galectin-3, serum creatinine, and cystatin C in chronic kidney diseases.
    Ji F; Zhang S; Jiang X; Xu Y; Chen Z; Fan Y; Wang W
    J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27726176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenin-A Proposed Biomarker for Cardiovascular Disease-Is Not Associated With Long-Term Survival in Patients With Peripheral Artery Disease.
    Höbaus C; Pesau G; Zierfuss B; Koppensteiner R; Schernthaner GH
    Angiology; 2021 Oct; 72(9):855-860. PubMed ID: 33779308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation and Clinical Implication of Galectin-9 Levels in Patients with Acute Coronary Syndrome and Chronic Kidney Disease.
    Xie JH; Zhu RR; Zhao L; Zhong YC; Zeng QT
    Curr Med Sci; 2020 Aug; 40(4):662-670. PubMed ID: 32862376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase 10 is associated with disease severity and mortality in patients with peripheral arterial disease.
    Martinez-Aguilar E; Gomez-Rodriguez V; Orbe J; Rodriguez JA; Fernández-Alonso L; Roncal C; Páramo JA
    J Vasc Surg; 2015 Feb; 61(2):428-35. PubMed ID: 25441671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin 3: association to neurohumoral activity, echocardiographic parameters and renal function in outpatients with heart failure.
    Stoltze Gaborit F; Bosselmann H; Kistorp C; Iversen K; Kumler T; Gustafsson F; Goetze JP; Sölétormos G; Tønder N; Schou M
    BMC Cardiovasc Disord; 2016 May; 16():117. PubMed ID: 27246703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in galectin-3, a biomarker of fibrosis, between participants with peripheral artery disease and participants with normal ankle-brachial index.
    Casanegra AI; Stoner JA; Tafur AJ; Pereira HA; Rathbun SW; Gardner AW
    Vasc Med; 2016 Oct; 21(5):437-444. PubMed ID: 27155290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function largely influences Galectin-3 prognostic value in heart failure.
    Zamora E; Lupón J; de Antonio M; Galán A; Domingo M; Urrutia A; Troya M; Bayes-Genis A
    Int J Cardiol; 2014 Nov; 177(1):171-7. PubMed ID: 25499371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3 as a Predictor of Long-term Survival After Isolated Coronary Artery Bypass Grafting Surgery.
    Parker DM; Owens SL; Ramkumar N; Likosky D; DiScipio AW; Malenka DJ; MacKenzie TA; Brown JR
    Ann Thorac Surg; 2020 Jan; 109(1):132-138. PubMed ID: 31336070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble ST2 and Galectin-3 as Predictors of Chronic Kidney Disease Progression and Outcomes.
    Kim AJ; Ro H; Kim H; Chang JH; Lee HH; Chung W; Jung JY
    Am J Nephrol; 2021; 52(2):119-130. PubMed ID: 33725696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-3 is associated with glomerular filtration rate and outcome in patients with stable decompensated cirrhosis.
    Oikonomou T; Goulis I; Ntogramatzi F; Athanasiadou Z; Vagdatli E; Akriviadis E; Cholongitas E
    Dig Liver Dis; 2019 Dec; 51(12):1692-1697. PubMed ID: 31235313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of galectin-3 and intestinal fatty acid binding protein as serum biomarkers in autosomal recessive polycystic kidney disease.
    Fleischer LT; Ballester L; Dutt M; Howarth K; Poznick L; Darge K; Furth SL; Hartung EA
    J Nephrol; 2023 Jan; 36(1):133-145. PubMed ID: 35980535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A translational study of Galectin-3 as an early biomarker and potential therapeutic target for ischemic-reperfusion induced acute kidney injury.
    Sun H; Peng J; Cai S; Nie Q; Li T; Kellum JA; Eliaz I; Peng Z
    J Crit Care; 2021 Oct; 65():192-199. PubMed ID: 34225083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.